News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
BAY CITY CAPITAL LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/07/2021 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 11.9% stake in Madrigal Pharmaceuticals, Inc. |
| 09/04/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 18.6% stake in Madrigal Pharmaceuticals, Inc. |
| 06/01/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 27.9% stake in Madrigal Pharmaceuticals, Inc. |
| 02/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/13/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 6.5% stake in Dermira, Inc. |
| 12/13/2019 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 27.1% stake in Madrigal Pharmaceuticals, Inc. |
| 10/17/2019 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 34.8% stake in Madrigal Pharmaceuticals, Inc. |
| 11/28/2018 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 9.3% stake in Merus N.V. |
| 02/10/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/05/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 07/22/2013 |
SC 13D/A
| HYPERION THERAPEUTICS INC reports a 10.6% stake in Hyperion Therapeutics, Inc. |
| 11/17/2010 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 93.6% stake in VIA Pharmaceuticals, Inc. |
| 07/01/2010 |
SC 13D/A
| BAY CITY CAPITAL LLC has filed a Schedule 13D for Sunesis Pharmaceuticals, Inc. |
| 03/30/2010 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 91.3% stake in VIA Pharmaceuticals, Inc. |
| 11/03/2009 |
SC 13D/A
| BAY CITY CAPITAL LLC has filed a Schedule 13D for Sunesis Pharmaceuticals, Inc. |
|
|